Related Experiment Video

Updated: Aug 17, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells

Teruhiko Fujii1, Anna M Nakamura, Goro Yokoyama

  • 1Department of Surgery, Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka, 830-0011, Japan. tfujii@med.kurume-u.ac.jp

Oncology Reports
|July 14, 2005
PubMed

Insights

Antineoplaston A10, a peptide derivative, effectively halts breast cancer cell growth by arresting them in the G1 phase. This mechanism involves regulating protein kinase C (PKC) and mitogen-activated protein kinase (MAPK) signaling pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Antineoplastons are naturally occurring peptides and amino acid derivatives.
  • They exhibit potential in controlling neoplastic cell growth.
  • Understanding their precise mechanism against cancer is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the antitumor mechanism of antineoplaston A10.
  • To elucidate the effects of A10 on breast cancer cell line SKRB-3.
  • To identify the specific signaling pathways involved in A10's anti-proliferative action.

Main Methods:

  • Treatment of SKRB-3 cells with antineoplaston A10.
  • Monitoring of cell cycle progression.
  • Analysis of protein kinase C (PKC) expression.
  • Assessment of mitogen-activated protein kinase (MAPK) phosphorylation, specifically extracellular signal-regulated kinase (ERK).
  • Evaluation of p16, p21, and Rb protein phosphorylation levels.

Main Results:

  • Antineoplaston A10 significantly inhibited SKRB-3 cell proliferation.
  • A10 treatment induced cell cycle arrest at the G1 phase.
  • A10 down-regulated PKCalpha protein expression.
  • This led to the inhibition of ERK/MAPK phosphorylation.
  • Increased expression of p16 and p21 proteins was observed, inhibiting Rb phosphorylation and causing G1 arrest.

Conclusions:

  • Antineoplaston A10 arrests SKRB-3 breast cancer cells in the G1 phase.
  • The G1 arrest is mediated through the downregulation of PKCalpha and subsequent inhibition of MAPK signaling.
  • These findings suggest antineoplaston A10 as a potential therapeutic agent for breast cancer.

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: